Jubilant Life Sciences | Zee News

Advertisement

NewsJubilant Life Sciences

Jubilant Life Sciences News

Jubilant Life Sciences

01 Dec 2015

Jubilant Life zooms 10% as firm gets USFDA nod for drug

Jubilant Life Sciences shares soared almost 10 per cent, to touch its 52-week high level today, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.

14 Sep 2015

Jubilant to market Technegas in US, signs pact with Cyclopharm

Technegas is an imaging agent primarily used in Pulmonary Embolism (blockage of lung arteries).

17 Jun 2015

Jubilant Life shares gain over 2% at close

Trimming most of its initial gains on profit-booking, shares of Jubilant Life Sciences ended over 2 percent higher on Wednesday.

Hypertension drug

06 Jan 2015

Aurobindo, Lupin & Jubilant get USFDA nod for hypertension drug

Three domestic firms, Aurobindo Pharma, Lupin and Jubilant Life Sciences, have received final approval from US health regulator to sell generic copies of Valsartan tablets used for treatment of hypertension.

Jubilant Life Sciences

23 Dec 2014

Jubilant acquires all outstanding shares of Cadista Holdings

Jubilant Life Sciences has completed tender offer to acquire all outstanding shares of Cadista Holdings Inc, thereby making the US-based firm as its wholly-owned subsidiary.

Loading...

NEWS ON ONE CLICK